The impact of chemotherapy shortages on COG and local clinical trials: A report from the Children's Oncology Group

E-ISSN： 1545-5017|62|6|940-944

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.6, 2015-06, pp. : 940-944

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of in‐patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 10, 2015-10 ,pp. : 1775-1781

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of administrative/billing data to expected protocol‐mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 7, 2015-07 ,pp. : 1184-1189

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy—a report from the Children's Oncology Group

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 49, Iss. 7, 2007-12 ,pp. : 894-900

John Wiley & Sons Inc

Access to resources Recommend Favorite

Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: A report from the children's oncology group

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 4, 2014-04 ,pp. : 729-736

John Wiley & Sons Inc

Access to resources Recommend Favorite

Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 7, 2015-07 ,pp. : 1171-1175

John Wiley & Sons Inc

Access to resources Recommend Favorite